Krejci, Marta <br/><br/>
Long-term outcomes of autologous transplantation in multiple myeloma: significant survival benefit of novel drugs in post-transplantation relapse.  [electronic resource] 

 -  Clinical lymphoma & myeloma  Dec 2009 
 - 436-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1938-0712 
<br/><br/><label>Standard No.: </label>10.3816/CLM.2009.n.086  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Boronic Acids--therapeutic use<br/>Bortezomib<br/>Disease Progression<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Middle Aged<br/>Multiple Myeloma--mortality<br/>Pyrazines--therapeutic use<br/>Recurrence<br/>Thalidomide--therapeutic use<br/>Transplantation, Autologous<br/>Treatment Outcome